TABLE 1.
Synthetic peptides derived from the HSRV Gag sequence and analyzed for susceptibility to cleavage by the HSRV PR
| No. of peptide | Peptide sequencea | Position within Gag | PR assay result | Turnover (nmol/60 min [%]) |
|---|---|---|---|---|
| 1 | PRAVNPHTMFMIS | 76–87 | Not cleaved | |
| 2 | DELEDVLNTQSEI | 141–153 | Not cleaved | |
| 3 | RSFSGLPSLPSIPGRb | 199–211 | Not cleaved | |
| 4 | PIQHIR↓SVTGE | 306–316 | Cleaved | 0.25 (15) |
| 5 | PAIDGVF↓PVTTPDLRCRIIN↓AILGGNI | 333–359 | Cleaved twice | NDc |
| 6 | PDGVF↓PVTTPDLRb | 336–347 | Cleaved | ND |
| 7 | PRCRIIN↓AILGG | 347–357 | Cleaved | 0.60 (36) |
| 8 | PGNIGLSLTPGDCLTWDS | 357–372 | Not cleaved | |
| 9 | PMHQLGNVIKG | 387–397 | Not cleaved | |
| 10 | PRAVN↓TVTQRb | 618–625 | Cleaved | 1.65 (100) |
N termini were modified by adding a Pro residue for fluorogenic assays. Residues in boldface flank the cleavage sites (arrows).
C termini were modified by adding an Arg residue for higher solubility.
ND, not done.